Comparison

CEF8, Influenza Virus NP (383-391) European Partner

Item no. TMO-TP1527-500mg
Manufacturer TargetMol
CASRN 142479-13-8
Amount 500 mg
Quantity options 100 mg 10 mg 1 mg 200 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Smiles C([C@H](NC([C@H](CC1=CC=C(O)C=C1)NC([C@@H](NC([C@H](CO)N)=O)CCCNC(=N)N)=O)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CCCNC(=N)N)C(O)=O)=O)[C@@H](C)O)=O)CCCNC(=N)N)=O)[C@H](CC)C)=O)C)=O)C=2C=3C(NC2)=CC=CC3
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias CEF8,Influenza Virus NP 383-391
Shipping Condition Cool pack
Available
Manufacturer - Targets
Others
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
1208.37
Description
CEF8, Influenza Virus NP (383-391), is an influenza A virus nucleoprotein containing residues 383 to 391, and it is the most important HLA-B*2705-restricted epitope in the nucleoprotein of influenza A viruses, associated with escape from cytotoxic T lymphocytes-mediated immunity. [HLA-B*3501 restricted influenza virus nucleoprotein epitope (383-391).]
Pathways
Others

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close